Prognostic Significance of Contrast Enhancement in Newly Diagnosed Grade 2 IDH-mutant Glioma

Vihang Nakhate, Aleksandra B Lasica, Loai Aker, Julie J Miller, Ian Pan, Jason Lauer, Julien Rousseau, Elisa Aquilanti, Isabel Arrillaga-Romany, Tamar R Berger, Tracy T Batchelor, Rameen Beroukhim, Ugonma N Chukwueke, Jorg Dietrich, Deborah A Forst, Elizabeth R Gerstner, L Nicolas Gonzalez Castro, Eudocia Q Lee, Lakshmi Nayak, Scott R Plotkin, John Y Rhee, Nancy Wang, David A Reardon, Raymond Y Huang, Gilbert Youssef, Patrick Y Wen

Open source

DOI: 10.1093/neuonc/noag262
Published: 2026-10-16
Container: Neuro-Oncology
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/neuonc/noag262,
  title = {Prognostic Significance of Contrast Enhancement in Newly Diagnosed Grade 2 IDH-mutant Glioma},
  author = {Vihang Nakhate and Aleksandra B Lasica and Loai Aker and Julie J Miller and Ian Pan and Jason Lauer and Julien Rousseau and Elisa Aquilanti and Isabel Arrillaga-Romany and Tamar R Berger and Tracy T Batchelor and Rameen Beroukhim and Ugonma N Chukwueke and Jorg Dietrich and Deborah A Forst and Elizabeth R Gerstner and L Nicolas Gonzalez Castro and Eudocia Q Lee and Lakshmi Nayak and Scott R Plotkin and John Y Rhee and Nancy Wang and David A Reardon and Raymond Y Huang and Gilbert Youssef and Patrick Y Wen},
  year = {2026},
  journal = {Neuro-Oncology},
  doi = {10.1093/neuonc/noag262},
  url = {https://doi.org/10.1093/neuonc/noag262}
}

RIS

TY  - JOUR
TI  - Prognostic Significance of Contrast Enhancement in Newly Diagnosed Grade 2 IDH-mutant Glioma
AU  - Vihang Nakhate
AU  - Aleksandra B Lasica
AU  - Loai Aker
AU  - Julie J Miller
AU  - Ian Pan
AU  - Jason Lauer
AU  - Julien Rousseau
AU  - Elisa Aquilanti
AU  - Isabel Arrillaga-Romany
AU  - Tamar R Berger
AU  - Tracy T Batchelor
AU  - Rameen Beroukhim
AU  - Ugonma N Chukwueke
AU  - Jorg Dietrich
AU  - Deborah A Forst
AU  - Elizabeth R Gerstner
AU  - L Nicolas Gonzalez Castro
AU  - Eudocia Q Lee
AU  - Lakshmi Nayak
AU  - Scott R Plotkin
AU  - John Y Rhee
AU  - Nancy Wang
AU  - David A Reardon
AU  - Raymond Y Huang
AU  - Gilbert Youssef
AU  - Patrick Y Wen
PY  - 2026
JO  - Neuro-Oncology
DO  - 10.1093/neuonc/noag262
UR  - https://doi.org/10.1093/neuonc/noag262
ER  -

APA

Nakhate, V., Lasica, A. B., Aker, L., Miller, J. J., Pan, I., Lauer, J., Rousseau, J., Aquilanti, E., Arrillaga-Romany, I., Berger, T. R., Batchelor, T. T., Beroukhim, R., Chukwueke, U. N., Dietrich, J., Forst, D. A., Gerstner, E. R., Castro, L. N. G., Lee, E. Q., Nayak, L., Plotkin, S. R., Rhee, J. Y., Wang, N., Reardon, D. A., Huang, R. Y., Youssef, G., & Wen, P. Y. (2026). Prognostic Significance of Contrast Enhancement in Newly Diagnosed Grade 2 IDH-mutant Glioma. Neuro-Oncology. https://doi.org/10.1093/neuonc/noag262

Source records

crossref · retrieved 2026-11-10T07:14:54.417Z